London: Trial of the vaccine developed by a joint effort by Oxford University and pharmaceutical company AstraZeneca has been resumed. The UK's Drug and Health Regulatory Authority (MHRA) has approved the re-introduction of the trial after it was called safe. It may be noted that the test was stopped for a few days when a volunteer in the trial of the vaccine had a serious symptom.

In Brazil, corona havoc continues as many cases come to the fore

Investigators found the trial safe: AstraZeneca and Oxford University reported that 'we could not give further information in the case but it is true that private investigators are describing the trial as safe. Based on this conclusion, the trial may resume.' AstraZeneca has said that "the oxford vaccine Azd 1222 has been re-trial in England. The security of the people present in this trial is our biggest problem," the company said.

Colombia burning in the fire of protests, 13 killed, 400 injured

Adherence to the best standards: Junha has revealed that we should adhere to the best standards in this trial. The company said that we will work closely with other countries in the world and decide when more trials are going to be started. It may be mentioned that after a standard review process, the vaccine was banned on 6th September on the world trial. An inquiry committee told the MHRA that the trial is being resumed in the UK.

30 people have been the victims of the devastation caused in the U.S. forest fire